Cortexyme Inc (the company was transformed to Quince Therapeutics (QNCX)) (CRTX) Announces Executive and Board Changes
Cortexyme Inc (the company was transformed to Quince Therapeutics (QNCX)) (CRTX) announced changes to its leadership team and board of directors.
The change is effective as of July 20, 2022.
Executive Changes Details:
Personnel Involved: Executive Officer
👥 Executive & Board Changes:
Personnel Involved: Executive Officer
Effective Dates: July 20, 2022, July 31, 2022, June 30, 2022, July 22, 2022
💼 Business Developments:
Partnership
Acquisition: Not available
Licensing: Not available
Regulatory Approval: Not available
Executive Changes
Structured Data:
Company Name: Cortexyme Inc (the company was transformed to Quince Therapeutics (QNCX))
📋 CORTEXYME, INC. (CRTX) - Executive Changes
Filing Date: 2022-07-22
Accepted: 2022-07-22 16:25:58
Event Type: Executive Changes
Event Details:
👥 Executive & Board Changes:
💼 Business Developments:
Structured Data: